Pravachol

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

41 competitors in Myelodysplastic Syndromes

#DrugCompanyPhaseTrials

1

Dacogen

Sun Pharmaceutical Industries, Inc.

Approved

182

Vidaza

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Approved

383

Cytosar

Teva

Approved

134

Idamycin

Pfizer

Approved

65

Reblozyl

Bristol-Myers Squibb

Phase 3

156

Evrenzo

Astellas

Phase 3

27

Xospata

Astellas

Phase 3

18

Rytelo

GGeron Corporation

Approved

—9

Fludara

Sanofi

Phase 2

510

Arava

Sanofi

Phase 2

1Show 27 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fasting Conditions3 trials

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Completed·—·Phase 1·NCT01146106·43 enrolled

Pravastatin Sodium 80 mg Tablets Under Fasting Conditions

Completed·Teva·Phase 1·NCT00830258·60 enrolled

Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions

Completed·Teva·Phase 1·NCT00834379·58 enrolled

Statin2 trials

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions

Completed·—·Phase 1·NCT01146093·24 enrolled

Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Unknown status·PPeking University Third Hospital·Phase 4·NCT04719481·110 enrolled

Acute Myeloid Leukemia2 trials

Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Terminated·FFred Hutchinson Cancer Center·Phase 1/2·NCT01342887·6 enrolled

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

Completed·SSWOG Cancer Research Network·Phase 2·NCT00840177·115 enrolled

Effectiveness1 trial

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00006412·630 enrolled

Liver Cancer1 trial

Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis

Completed·FFederation Francophone de Cancerologie Digestive·Phase 3·NCT01075555·323 enrolled

7 more indications

Endothelial Function1 trial

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Withdrawn·AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections·Phase 2·NCT01515813

Small Cell Lung Cancer1 trial

Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer

Completed·UUniversity College, London·Phase 3·NCT00433498·846 enrolled

Drug1 trial

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00017758·56 enrolled

Interaction1 trial

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00000941·56 enrolled

Lip1 trial

Detoxification From the Lipid Tract

Completed·PPachankis, Yang I., M.D.·Phase 4·NCT06357104·1 enrolled

Atorvastatin1 trial

Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

Completed·Bristol-Myers Squibb·Phase 4·NCT00382460·4,000 enrolled

Myelodysplastic Syndromes1 trial

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Completed·FFred Hutchinson Cancer Center·N/A·NCT01831232·24 enrolled

Regulatory

FDA Approval Timeline[4]

Details

Drug Info

Related News